Skip to Main Content

MDCC Roster


Stephen I. Katz, M.D., Ph.D. Acting Chair, MDCC
Director,
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland (MDCC Acting Chair; Federal Agency Representative)
Term End: 12/31/2017
Glen H. Nuckolls, Ph.D. Executive Secretary, MDCC
Program Director, Extramural Research Program
NIH/NINDS
Valerie A. Cwik, M.D.
Medical Director and Executive Vice President for Research, Muscular Dystrophy Association, Tucson, Arizona (Public Member)
Term End: 12/31/2017
Daniel Paul Perez
President and Chief Executive Officer,
Facioscapulohumeral Society, Inc., Watertown, Massachusetts (Public Member)
Term End: 12/31/2017
Brian Denger
Parent Advocate Coordinator, Parent Project Muscular Dystrophy, Biddeford, Maine (Public Member)
Term End: 12/31/2017
Wanda L. Salzer, M.D.
Director, Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Materiel Command, Fort Detrick, Maryland (Federal Agency Representative)
Term End: 12/31/2017
Devanand Jillapalli, M.D.
Medical Officer, Office of Orphan Products Development, Office of the Commissioner, Food and Drug Administration, Silver Spring, Maryland (Federal Agency Representative)
Term End: 12/31/2017
M. Theresa B. San Agustin, M.D.
Program Manager, National Institute on Disability, Independent Living and Rehabilitation Research, Administration of Community Living, Washington, District of Columbia (Federal Agency Representative)
Term End: 12/31/2017
James P. Kiley, Ph.D.
Director, Airway Biology and Division of Lung Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland (Federal Agency Representative)
Term End: 12/31/2017
Joan Scott, M.S., C.G.C.
Chief, Genetic Services Branch in the Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, Maryland (Federal Agency Representative)
Term End: 12/31/2017
Walter J. Koroshetz, M.D.
Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (Federal Agency Representative)
Term End: 12/31/2017
Peter H. Wald, M.D., M.P.H.
Vice President, Enterprise Medical Director, USAA, San Antonio, Texas (Public Member)
Term End: 12/31/2017

This Page Last Reviewed on February 1, 2016